Abstracts

Citation

Carolyn Bolton Moore, Edmund Capparelli, Kat Calabrese, Brookie Best, Shawn Ward, Cindy McCoig, Herta Crauwel, Allison Agwu, Pearl Samson, Barb Heckman, Susan Ford, Adeola Adeyeye, Jack Moye, Andres Camacho-Gonzalez, Aditya H. Gaur. Safety and PK of long-acting Cabotegravir and Rilpivirine in adolescents. Presented at: CROI 2022; 2022 Feb 16.

Citation

C. Cunningham, E. Capparelli, E. McFarland, P. Muresan, C. Perlowski, E. Smith, R. Hazra, L. Purdue, P. Harding, A. McDermott, J. Mascola, B. Graham. Safety and PK of Potent Anti-HIV Monoclonal AB VRC07-523LS in HIV-exposed Infants. Presented at: HIV R4P 2021; 2021 Jan 27.

Citation

Coleen K. Cunningham, M.D. Safety and tolerability of recombinant HIV-1 vaccines utilizing fowlpox and modified vaccinia ankara vector in HIV-1 infected young adults on highly active antiretroviral therapy. Presented at: 15th Conference on Retroviruses & Opportunistic Infections.

Citation

Ross E. McKinney, Jr., M.D. Safety and Tolerance of Zidovudine (ZDV, AZT, RETROVIR) During a Phase I Study in Children: Two Year Follow-Up.

Citation

Charles Debeaux Mitchell, M.D., Gwendolyn B. Scott, M.D., Susan Cecilia Hutto, M.D., Mary T. Mastrucci, M.D., John H. Gourley, R.N., B.S.N., A.C.R.N., C. Owens, M. Sajous. Safety and Tolerance of Zidovudine in Pediatric AIDS.

Citation

Sharon Appelbaum Nachman, M.D., Adriana Weinberg, M.D., Petronella Muresan, M.S., Mark J. Abzug, M.D., Ruth Ebiasah, Pharm.D., M.S., R.Ph., Elizabeth Petzold, Ph.D., Barbara E. Heckman, B.S., Heather D. Watts, M.D., Judi A. Miller, R.N., B.S.N., Myron Levin, M.D. Safety of an Inactivated Influenza A (H1N1) Monovalent Vaccine (H1N1 Vaccine) in HIV-1 Infected Pregnant Women. Presented at: 17th Conference on Retroviruses & Opportunistic Infections.

Citation

Lujan-Zilbermann J, Williams PL, Siberry GK, Read JS, Jean-Philippe P, Heckman BE, Meredith Warshaw, M.A., Sharon Appelbaum Nachman, M.D. Safety of quadrivalent meningococcal conjugate vaccine (MCV4) in HIV-infected youth. Presented at: 48th Intersci Conf on Antimicrobial Agents & Chemotherapy; 2008 Oct 26.

Citation

Coleen K. Cunningham, M.D., Diane W. Wara, M.D., Terence Fenton, Ed.D., Minhee Kang, M.S., Ph.D., Elizabeth Hawkins, James McNamara, M.D., Lynne M. Mofenson, M.D., F.A.A.P., Anne-Marie Duliege, M.D., M.S., Donald P. Francis, M.D., D.Sc., William Borkowsky, M.D. Safety of Recombinant HIV-1 Envelope Vaccines in Neonates Born to HIV-1 Infected Women.

Citation

Diane W. Wara, M.D. Safety of Recombinant HIV-1 Envelope Vaccines in Newborns of Infected Mothers - a Phase I Study.

Citation

Stuart E. Starr, M.D., Courtney V. Fletcher, Pharm.D., Stephen A. Spector, M.D., Richard Brundage, Pharm.D., Ph.D., Florence H. Yong, M.S., Douglas J. Manion, M.D., F.R.C.P. Safety, Pharmacokinetics And Antiviral Effect Of Efavirenz (EFV) Liquid Suspension In Combination With Neldinavir (NLF) and Nucleoside Reverse Transcriptase Inhibitors (NRTIs) In HIV-Infected Children.